Association between serum adalimumab concentrations and endoscopic disease activity in patients with Crohn's disease-Reference-Cited by-同舟云学术

Association between serum adalimumab concentrations and endoscopic disease activity in patients with Crohn's disease

Published:2016-11 Issue:11 Volume:31 Page:1831-1836
ISSN:0815-9319
Container-title:Journal of Gastroenterology and Hepatology
language:en
Short-container-title:Journal of Gastroenterology and Hepatology

Author:

Morita Yukihiro¹,Imaeda Hirotsugu¹,Nishida Atsushi¹,Inatomi Osamu¹,Bamba Shigeki¹,Sasaki Masaya¹,Tsujikawa Tomoyuki²,Sugimoto Mitsushige¹,Andoh Akira¹

Affiliation:

1. Department of Medicine; Shiga University of Medical Science; Otsu Japan

2. Department of Comprehensive Medicine; Shiga University of Medical Science; Otsu Japan

Funder

Ministry of Education, Culture, Sports, Science and Technology of Japan

Ministry of Health, Labor and Welfare of Japan

Japan Agency for Medical Research and Development

Smoking Research Foundation

Publisher

Wiley

Subject

Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jgh.13400/fullpdf

Reference39 articles.

1. Risk factors of work disability in patients with inflammatory bowel disease-a Dutch nationwide web-based survey: work disability in inflammatory bowel disease;Valk;J. Crohns Colitis,2014

2. Diet, microbes, and host genetics: the perfect storm in inflammatory bowel diseases;Leone;J. Gastroenterol.,2013

3. The role of diet on intestinal microbiota metabolism: downstream impacts on host immune function and health, and therapeutic implications;Goldsmith;J. Gastroenterol.,2014

4. Unravelling the pathogenesis of inflammatory bowel disease;Xavier;Nature,2007

5. Review article: infliximab for Crohn's disease treatment-shifting therapeutic strategies after 10 years of clinical experience;Danese;Aliment. Pharmacol. Ther.,2011

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent Advances in the Optimization of Anti-TNF Treatment in Patients with Inflammatory Bowel Disease;Journal of Clinical Medicine;2023-03-23

2. Adalimumab Concentration Changes After Dose Escalation in Inflammatory Bowel Disease;Therapeutic Drug Monitoring;2021-10

3. A Comprehensive Literature Review and Expert Consensus Statement on Therapeutic Drug Monitoring of Biologics in Inflammatory Bowel Disease;American Journal of Gastroenterology;2021-08-13

4. Non-Invasive Targeted Crohn’s Disease Management by Combining Endoscopic Healing Index and Therapeutic Drug Monitoring;Crohn's & Colitis 360;2021-06-09

5. Predictive value of blood concentration of biologics on endoscopic inactivity in inflammatory bowel disease: A systematic review;World Journal of Gastroenterology;2021-03-07